Combating Age-related Failure of Myelination in Multiple Sclerosis: An Exploratory Study
Part of paid clinical trials in Seattle, Washington.
- Sponsor
- University of Washington
- Study ID
- NCT07723599
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Observation — OTHERNo intervention is administered. Participants undergo observational assessments including MRI, wearable activity monitoring, and questionnaires.
Study Details
This observational, longitudinal study will examine whether physical activity and other potentially modifiable lifestyle factors are associated with changes in myelin, the protective coating around nerve fibers, in older adults with multiple sclerosis (MS). Participants will undergo magnetic resonance imaging (MRI) scans to measure myelin throughout the central nervous system and will wear wrist-worn activity trackers to assess physical activity over time.
Key Dates
- First listed
- Jul 23, 2026
- Start date
- Aug 31, 2026
- Status verified
- Jul 2026
- Primary completion
- Jun 30, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 14 participants (estimated)
Arms
- Arm: Adults With Multiple SclerosisParticipants with multiple sclerosis, age 50-70 (inclusive) will undergo quantitative MRI assessments, wearable activity monitoring, and questionnaire-based assessments over the study period.
Primary Outcome Measure
Quantitative MRI-derived myelin measure [ Time Frame: Baseline and 6 months ]
Central Contacts
- Susan R Robles, BS206-598-0501
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Multiple Sclerosis Center at UW Medical Center - Northwest | Seattle | Washington | 98133 | Sarah B Simmons, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Seattle, WA
Related Studies
- Complementary and Alternative Care in Multiple SclerosisRecruiting · Bastyr University · Kenmore, Washington
- A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)PHASE1 · Recruiting · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · Irvine, California
- A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)Recruiting · TG Therapeutics, Inc. · Birmingham, Alabama
- Confirmatory Trial for Alleviating Fatigue in Multiple SclerosisRecruiting · Accelerated Cure Project for Multiple Sclerosis · Washington D.C., District of Columbia